| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Division of Medical Sciences, University of Birmingham, Queen Elizabeth Hospital, Edgbaston, Birmingham B15 2TH, UK
1 Cedars-Sinai Research Institute, UCLA School of Medicine, Los Angeles, CA 90048, USA
2 Institute for Cancer Studies, University of Birmingham, Queen Elizabeth Hospital, Edgbaston, Birmingham B15 2TH, UK
(Requests for offprints should be addressed to K Boelaert; Email: k.boelaert{at}bham.ac.uk)
* (K Boelaert and R Yu contributed equally to this work)
Human pituitary tumor-transforming gene (PTTG), known also as securin, is a multifunctional protein implicated in the control of mitosis and the pathogenesis of thyroid, colon, oesophageal and other tumour types. Critical to PTTG function is a C-terminal double PXXP motif, forming a putative SH3-interacting domain and housing the gene’s sole reported phosphorylation site. The exact role of phosphorylation and PXXP structure in the modulation of PTTG action in vitro remains poorly understood. We therefore examined the mitotic, transformation, proliferation and transactivation function of the C-terminal PXXP motifs of human PTTG. Live-cell imaging studies using an EGFP-PTTG construct indicated that PTTG’s regulation of mitosis is retained regardless of phosphorylation status. Colony-formation assays demonstrated that phosphorylation of PTTG may act as a potent inhibitor of cell transformation. In proliferation assays, NIH-3T3 cells stable transfected and overexpressing mutations preventing PTTG phosphorylation (Phos-) showed significantly increased [3H]thymidine incorporation compared with WT, whereas mutants mimicking constitutive phosphorylation of PTTG (Phos+) exhibited reduced cell proliferation. We demonstrated that PTTG transactivation of FGF-2 in primary thyroid and PTTG-null cell lines was not affected by PTTG phosphorylation but was prevented by a mutant disrupting the PXXP motifs (SH3-). Taken together, our data suggest that PXXP structure and phosphorylation are likely to exert independent and critical influences upon PTTG’s diverse actions in vitro.
This article has been cited by other articles:
|
|
 |
|
  F. Salehi, K. Kovacs, B. W. Scheithauer, D. Cantelmi, E. Horvath, R. V. Lloyd, and M. Cusimano Immunohistochemical Expression of Pituitary Tumor Transforming Gene (PTTG) in Pituitary Adenomas: A Correlative Study of Tumor Subtypes International Journal of Surgical Pathology, February 1, 2010; 18(1): 5 - 13. [Abstract] [PDF]
|
|
|
|
 |
|
 Y. Tong and T. Eigler Transcriptional targets for pituitary tumor-transforming gene-1 J. Mol. Endocrinol., November 1, 2009; 43(5): 179 - 185. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Salehi, K. Kovacs, B. W Scheithauer, R. V Lloyd, and M. Cusimano Pituitary tumor-transforming gene in endocrine and other neoplasms: a review and update Endocr. Relat. Cancer, September 1, 2008; 15(3): 721 - 743. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Vlotides, T. Eigler, and S. Melmed Pituitary Tumor-Transforming Gene: Physiology and Implications for Tumorigenesis Endocr. Rev., April 1, 2007; 28(2): 165 - 186. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. van de Pavert, J. Meuleman, A. Malysheva, W. M. Aartsen, I. Versteeg, F. Tonagel, W. Kamphuis, C. J. McCabe, M. W. Seeliger, and J. Wijnholds A Single Amino Acid Substitution (Cys249Trp) in Crb1 Causes Retinal Degeneration and Deregulates Expression of Pituitary Tumor Transforming Gene Pttg1 J. Neurosci., January 17, 2007; 27(3): 564 - 573. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Yu, M. Cruz-Soto, S. L. Calzi, H. Hui, and S. Melmed Murine pituitary tumor-transforming gene functions as a securin protein in insulin-secreting cells. J. Endocrinol., October 1, 2006; 191(1): 45 - 53. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S-Y Chan, J A Franklyn, H N Pemberton, J N Bulmer, T J Visser, C J McCabe, and M D Kilby Monocarboxylate transporter 8 expression in the human placenta: the effects of severe intrauterine growth restriction. J. Endocrinol., June 1, 2006; 189(3): 465 - 471. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. S. Kim, J. A. Franklyn, A. L. Stratford, K. Boelaert, J. C. Watkinson, M. C. Eggo, and C. J. McCabe Pituitary Tumor-Transforming Gene Regulates Multiple Downstream Angiogenic Genes in Thyroid Cancer J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 1119 - 1128. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Stratford, K. Boelaert, L. A. Tannahill, D. S. Kim, A. Warfield, M. C. Eggo, N. J. L. Gittoes, L. S. Young, J. A. Franklyn, and C. J. McCabe Pituitary Tumor Transforming Gene Binding Factor: A Novel Transforming Gene in Thyroid Tumorigenesis J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4341 - 4349. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
